{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:57:07Z","timestamp":1766516227671,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100019631","name":"SCOR Corporate Foundation for Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019631","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.euo.2025.04.024","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T16:04:46Z","timestamp":1746806686000},"page":"871-874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Eliciting the Impact of Metformin and Statins on Prostate Cancer Outcomes from a Real-life National Database Analysis"],"prefix":"10.1016","volume":"8","author":[{"given":"Olivier","family":"Cussenot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoann","family":"Taille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Jacques","family":"Portal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9raldine","family":"Cancel-Tassin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"de la Taille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Ploussard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Vicaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.04.024_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.843458","article-title":"The impact of metabolic syndrome and type 2 diabetes mellitus on prostate cancer","volume":"10","author":"Sousa","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.euo.2025.04.024_b0010","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1210\/clinem\/dgad450","article-title":"New horizons: epidemiology of obesity, diabetes mellitus, and cancer prognosis","volume":"109","author":"Harborg","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.euo.2025.04.024_b0015","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41391-022-00557-y","article-title":"Statins and prostate cancer\u2014hype or hope? The biological perspective","volume":"25","author":"Longo","year":"2022","journal-title":"Prostate Cancer Prostat Dis"},{"key":"10.1016\/j.euo.2025.04.024_b0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.42676","article-title":"Statin use and survival among men receiving androgen-ablative therapies for advanced prostate cancer: a systematic review and meta-analysis","volume":"5","author":"Jayalath","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euo.2025.04.024_b0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/ph15020131","article-title":"The effects of statins on prostate cancer patients receiving androgen deprivation therapy or definitive therapy: a systematic review and meta-analysis","volume":"15","author":"Hou","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.euo.2025.04.024_b0030","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/j.eururo.2024.01.030","volume":"86","author":"Cussenot","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.04.024_b0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jamaoncol.2017.2752","article-title":"Examining bias in studies of statin treatment and survival in patients with cancer","volume":"4","author":"Emilsson","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euo.2025.04.024_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0314761","article-title":"Utilising causal inference methods to estimate effects and strategise interventions in observational health data","volume":"19","author":"Duong","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.euo.2025.04.024_b0045","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5311828","article-title":"The impact of metformin use with survival outcomes in urologic cancers: a systematic review and meta-analysis","volume":"2021","author":"Yao","year":"2021","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.euo.2025.04.024_b0050","doi-asserted-by":"crossref","first-page":"595","DOI":"10.7314\/APJCP.2015.16.2.595","article-title":"Metformin association with lower prostate cancer recurrence in type 2 diabetes: a systematic review and meta-analysis","volume":"16","author":"Hwang","year":"2015","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258893112500121X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258893112500121X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T19:25:48Z","timestamp":1762629948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258893112500121X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S258893112500121X"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.04.024","relation":{},"ISSN":["2588-9311"],"issn-type":[{"type":"print","value":"2588-9311"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eliciting the Impact of Metformin and Statins on Prostate Cancer Outcomes from a Real-life National Database Analysis","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}